Sunitinib enhances the antitumor responses of agonistic CD40-antibody by reducing MDSCs and synergistically improving endothelial activation and T-cell recruitment

被引：0
|
作者：
van Hooren, Luuk
Georganaki, Maria
Huang, Hua
Mangsbo, Sara
Dimberg, Anna
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-1485
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1485
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Activation of myeloid and endothelial cells by CD40L gene therapy supports T-cell expansion and migration into the tumor microenvironment
    E Eriksson
    R Moreno
    I Milenova
    L Liljenfeldt
    L C Dieterich
    L Christiansson
    H Karlsson
    G Ullenhag
    S M Mangsbo
    A Dimberg
    R Alemany
    A Loskog
    Gene Therapy, 2017, 24 : 92 - 103
  • [22] Activation of myeloid and endothelial cells by CD40L gene therapy supports T-cell expansion and migration into the tumor microenvironment
    Eriksson, E.
    Moreno, R.
    Milenova, I.
    Liljenfeldt, L.
    Dieterich, L. C.
    Christiansson, L.
    Karlsson, H.
    Ullenhag, G.
    Mangsbo, S. M.
    Dimberg, A.
    Alemany, R.
    Loskog, A.
    GENE THERAPY, 2017, 24 (02) : 92 - 103
  • [23] A trispecific antibody induces potent tumor-directed T-cell activation and antitumor activity by CD3/CD28 co-engagement
    Chen, Li
    Qian, Wenjing
    Pan, Fangfang
    Li, Debin
    Yu, Weiwei
    Tong, Li
    Yang, Yingying
    Xu, Qiming
    Ding, Jianfeng
    Dai, Ruixue
    Xian, Weiwei
    Zhu, Xufeng
    Ren, Pu
    Zhu, Huaxing
    IMMUNOTHERAPY, 2024, 16 (03) : 143 - 159
  • [24] RPA-2.10 - AN ANTI-CD2 MONOCLONAL-ANTIBODY THAT INHIBITS ALLOIMMUNE RESPONSES AND MONITORS T-CELL ACTIVATION
    AVERSA, GG
    BISHOP, GA
    SURANYI, MG
    HALL, BM
    TRANSPLANTATION PROCEEDINGS, 1987, 19 (01) : 277 - 278
  • [25] A Bispecific DLL3/CD3 IgG-Like T-Cell Engaging Antibody Induces Antitumor Responses in Small Cell Lung Cancer
    Hipp, Susanne
    Voynov, Vladimir
    Drobits-Handl, Barbara
    Giragossian, Craig
    Trapani, Francesca
    Nixon, Andrew E.
    Scheer, Justin M.
    Adam, Paul J.
    CLINICAL CANCER RESEARCH, 2020, 26 (19) : 5258 - 5268
  • [26] CD40 LIGAND-INDEPENDENT B-CELL ACTIVATION REVEALED BY CD40 LIGAND-DEFICIENT T-CELL CLONES - EVIDENCE FOR DISTINCT ACTIVATION REQUIREMENTS FOR ANTIBODY-FORMATION AND B-CELL PROLIFERATION
    LANE, P
    BURDET, C
    MCCONNELL, F
    LANZAVECCHIA, A
    PADOVAN, E
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (06) : 1788 - 1793
  • [27] Abbreviated T-Cell Activation on the Automated Clinimacs Prodigy Device Enhances Bispecific CD19/22 Chimeric Antigen Receptor T-Cell Viability and Fold Expansion, Reducing Total Culture Duration
    Srivastava, Sandeep K.
    Panch, Sandhya R.
    Jin, Jianjian
    Shalabi, Haneen
    Shah, Nirali N.
    Highfill, Steven L.
    Stroncek, David F.
    BLOOD, 2018, 132
  • [28] Concomitant blockade of A2AR and CTLA-4 by siRNA-loaded polyethylene glycol-chitosan-alginate nanoparticles synergistically enhances antitumor T-cell responses
    Ghasemi-Chaleshtari, Mitra
    Kiaie, Seyed Hossein
    Irandoust, Mahzad
    Karami, Hadis
    Afjadi, Mohsen Nabi
    Ghani, Sepideh
    Vanda, Nasimeh Aghaei
    Sede, Mohammad Javad Ghaderi
    Ahmadi, Armin
    Masjedi, Ali
    Hassannia, Hadi
    Atyabi, Fatemeh
    Hojjat-Farsangi, Mohammad
    Namdar, Afshin
    Ghalamfarsa, Ghasem
    Jadidi-Niaragh, Farhad
    JOURNAL OF CELLULAR PHYSIOLOGY, 2020, 235 (12) : 10068 - 10080
  • [29] FS118, a Bispecific Antibody Targeting LAG-3 and PD-L1, Enhances T-Cell Activation Resulting in Potent Antitumor Activity
    Kraman, Matthew
    Faroudi, Mustapha
    Allen, Natalie L.
    Kmiecik, Katarzyna
    Gliddon, Daniel
    Seal, Claire
    Koers, Alexander
    Wydro, Mateusz M.
    Batey, Sarah
    Winnewisser, Julia
    Young, Lesley
    Tuna, Mihriban
    Doody, Jacqueline
    Morrow, Michelle
    Brewis, Neil
    CLINICAL CANCER RESEARCH, 2020, 26 (13) : 3333 - 3344
  • [30] Adenovirus-mediated CD40 ligand gene-engineered dendritic cells elicit enhanced CD8+ cytotoxic T-cell activation and antitumor immunity
    Liu, YQ
    Zhang, XS
    Zhang, WD
    Chen, Z
    Chan, T
    Ali, K
    Jia, ZC
    Xiang, J
    CANCER GENE THERAPY, 2002, 9 (02) : 202 - 208
12345